Soluble Tumor Necrosis Factor-α Receptors in Young Obese Subjects With Normal and Impaired Glucose Tolerance
- 1 March 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (3), 875-880
- https://doi.org/10.2337/diacare.26.3.875
Abstract
OBJECTIVE— Tumor necrosis factor-α (TNF-α) is a possible link between obesity and impaired glucose tolerance (IGT) and type 2 diabetes. Data about TNF-α and soluble forms of its receptors (sTNFR1 and sTNFR2) in IGT are controversial. The aim of the present study was to assess plasma TNF-α, sTNFR1, and sTNFR2 levels and to evaluate the relationships with insulin resistance in obese subjects with IGT. RESEARCH DESIGN AND METHODS— A total of 104 subjects participated in the present study: 30 obese subjects with IGT (obese-IGT), 32 obese subjects with normal glucose tolerance (obese-NGT), and 42 lean healthy control subjects (control-NGT). Anthropometry and blood biochemical parameters were measured and euglycemic-hyperinsulinemic clamp was performed. RESULTS— Obese-IGT subjects were more insulin resistant in comparison with obese-NGT and control-NGT groups; obese-NGT subjects were more insulin resistant than control-NGT. Plasma sTNFR1 and sTNFR2 were markedly higher in both groups of obese subjects in comparison with control-NGT and in the obese-IGT versus obese-NGT group. Plasma sTNFR1 and sTNFR2 were inversely related to insulin sensitivity. Both relationships remained significant after adjustment for age, BMI, waist girth, percent body fat, plasma glucose, insulin, nonesterified fatty acids, cholesterol, and triglycerides. Correlation between sTNFR2 and insulin sensitivity was also present in all the groups analyzed separately, but the correlation between sTNFR1 and insulin sensitivity was present only in the obese-NGT group. CONCLUSIONS— Our data suggest that TNF-α receptors are increased in obese-IGT subjects and are related to insulin resistance. These findings indicate that the TNF-α system might contribute to the development of insulin resistance in glucose-intolerant subjects.Keywords
This publication has 28 references indexed in Scilit:
- Increased Plasma-Soluble Tumor Necrosis Factor-α Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic SubjectsDiabetes Care, 2002
- Plasma Levels of Tumor Necrosis Factor-α, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose ToleranceDiabetes Care, 2001
- Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjectsAtherosclerosis, 1999
- Plasma concentrations of soluble TNF-alpha receptors in obese subjectsInternational Journal of Obesity, 1998
- TrueInternational Journal of Obesity, 1998
- Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor- System in HumansJournal of Clinical Endocrinology & Metabolism, 1997
- Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.JCI Insight, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.JCI Insight, 1995
- The colorimetric micro-determination of non-esterified fatty acids in plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1964